Particle.news

WHO Warns Most COPD Cases Go Undiagnosed, Urges Wider Testing

Scaling spirometry in primary care alongside stronger air-quality and tobacco controls would catch disease earlier, reducing deaths.

Overview

  • WHO officials and lung experts highlighted a vast diagnostic gap that leaves more than 70% of people with COPD unidentified, a problem they say hides the true size of the global burden.
  • Argentina’s EPOC.AR study found a 14.5% COPD prevalence in surveyed areas and reported that about 77% of people with the condition had never been diagnosed, illustrating the gap at national level.
  • Spirometry is the standard, low-cost test to confirm COPD but is underused because primary-care teams lack training, time and prioritization, and technicians can be trained to perform the test reliably.
  • Early diagnosis matters because stopping smoking, pulmonary rehabilitation and other treatments can slow disease progression and preserve daily function, while delayed diagnosis forces reliance on oxygen and heavy medications.
  • The WHO’s WA78.5 resolution frames an integrated lung-health response that links scaled testing to prevention measures such as cleaner air rules, occupational safeguards and stronger tobacco and vaping controls.